Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

OBJECTIVE: To evaluate golimumab's effect on MRI-detected spinal inflammation in ankylosing spondylitis (AS). METHODS: Patients were randomly assigned to subcutaneous injections of placebo (n=78), golimumab 50 mg (n=138), or golimumab 100 mg (n=140) every 4 weeks. An MRI substudy comprising 98...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert A, van der Heijde, Désirée, Inman, Robert D, Deodhar, Atul A, Baratelle, Anna, Xu, Stephen, Xu, Weichun, Hsu, Benjamin
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2011
Sujets:
Clinical and Epidemiological Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3371220/
https://ncbi.nlm.nih.gov/pubmed/22128083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2011-200308
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires